According to IQ4I estimations, the prefilled syringes global market is expected to reach $10,273.8 million by 2028, growing at a high single digit CAGR from 2021 to 2028. The report covers business intelligence information and analysis of various PFS market segments based on the material, design, closure system, product, application, molecule type, usability, route of administration and geography. Glass PFS segment held the largest share or revenue in 2021 and is expected to grow at a high single digit CAGR while Polymer PFS segment is the fastest emerging segment that is expected of growing at a double digit CAGR during the forecasted period. Single chamber prefilled syringes segment fetched the largest revenue in 2021 and is expected of growing at a high single digit CAGR while Dual chamber PFS segment is the fastest emerging segment that is expected of growing at a double digit CAGR from 2021 to 2028. The segments of Staked Needle PFS, Large molecule PFS, Subcutaneous PFS and Disposable PFS accounted for the largest revenue in 2021 and are also the fastest growing segments in their respective categories and these are all expected of growing at a high single digit CAGR during the forecasted period. Complete PFS Systems segment holds the largest revenue in 2021 and is expected to grow at a high single digit CAGR while Accessory devices segment is the fastest emerging segment that is expected of growing at a high single digit CAGR during the forecast period. The Heparin PFS application segment accounted for the largest revenue in 2021 and is expected to grow at a mid-single digit CAGR while Therapeutic Drugs PFS segment is the fastest emerging segment that is expected of growing at a low teen CAGR from 2021 to 2028. Even though Europe dominates the PFS market currently and is expected to grow at a mid-single digit CAGR, Asia-Pacific region is the fastest emerging region that is expected of growing a double digit CAGR during the forecasted period.